Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3007 studies found for:    Open Studies | "Lung Diseases"
Show Display Options
Rank Status Study
21 Unknown  Prevention of Chronic Lung Disease (CLD) in Preterm Infants
Conditions: Respiratory Distress Syndrome;   Chronic Lung Disease of Prematurity
Interventions: Drug: budesonide;   Drug: surfactant and air (placebo)
22 Unknown  Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease
Condition: Lung Disease
Intervention: Other: The Hospital2Home Service
23 Recruiting Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease
Conditions: Chronic Lung Disease;   Bronchopulmonary Dysplasia
Interventions: Drug: Spironolactone;   Drug: Placebo
24 Unknown  Interstitial Lung Disease Questionnaire
Condition: Interstitial Lung Disease
Intervention:
25 Recruiting Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Conditions: Asthma;   Chronic Obstructive Pulmonary Disease;   Interstitial Lung Disease;   Cystic Fibrosis;   Pulmonary Hypertension
Intervention: Drug: Xenon
26 Recruiting Identification of Novel Markers of Human Lung Disease
Condition: Lung Diseases, Interstitial
Intervention: Other: novel biomarkers of lung disease
27 Recruiting UPMC Simmons Center for Interstitial Lung Disease Pennsylvania Statewide Research Registry
Condition: Lung Diseases, Interstitial
Intervention:
28 Recruiting The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples
Conditions: Asthma;   Chronic Obstructive Lung Disease
Intervention: Other: Breath sample in all patients
29 Unknown  Blood Collection From Individuals With Lung Disease for Genetic Studies
Conditions: Asthma;   COPD;   Interstitial Lung Disease;   Cystic Fibrosis;   Lung Cancer
Intervention:
30 Recruiting Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
Conditions: Systemic Sclerosis;   Interstitial Lung Diseases
Intervention:
31 Unknown  Trefoil Peptides in Lung Diseases
Conditions: Chronic Obstructive Pulmonary Disease;   Asthma
Intervention:
32 Recruiting Diagnostic Yield of Transbronchial Cryobiopsy in Diagnosis of Interstitial Lung Diseases
Condition: Interstitial Lung Disease
Intervention: Other: Transbronchial lung cryobiopsy
33 Recruiting Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease
Condition: Interstitial Lung Disease
Interventions: Procedure: Transbronchial biopsy;   Procedure: Cryoprobe biopsy;   Procedure: VATS biopsy
34 Recruiting Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD)
Condition: Interstitial Lung Disease
Interventions: Procedure: Cryobiopsy biopsy;   Procedure: Transbronchial Biopsy;   Procedure: VATS biopsy
35 Unknown  Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant
Conditions: Respiratory Tract Infections;   Bronchiolitis Obliterans;   Cryptogenic Organizing Pneumonia;   Lung Diseases, Interstitial
Interventions: Drug: Prednisone;   Drug: Azithromycin;   Drug: Montelukast;   Drug: Symbicort
36 Recruiting The Canadian Cohort Obstructive Lung Disease
Conditions: COPD;   Chronic Obstructive Pulmonary Disease
Intervention:
37 Recruiting Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Conditions: Pulmonary Hypertension;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Tadalafil;   Drug: placebo
38 Recruiting Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease
Conditions: Asthma;   Chronic Obstructive Pulmonary Disease;   Obstructive Sleep Apnea
Intervention: Drug: Inhaled Fluticasone Propionate
39 Recruiting Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
Conditions: Pulmonary Fibrosis;   Lung Disease
Intervention:
40 Unknown  End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
Conditions: Chronic Obstructive Pulmonary Disease;   End-of-Life Fear;   Fear About Death and Dying;   Depression
Intervention: Behavioral: A brief psycho-educational intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years